Steril-gene Life Sciences Private Limited

Steril-Gene Life Sciences Private Limited, incorporated on February 28, 2007, is a privately held Indian pharmaceutical company specializing in the development and manufacturing of finished pharmaceutical formulations. The company is headquartered at New No.15, Old No.7, Gopalakrishnan Road, T. Nagar, Chennai, Tamil Nadu 600017, India. It operates a state-of-the-art manufacturing facility in Puducherry, India, built to US FDA standards, covering approximately 81,000 square meters and operational since 2010. The facility produces a diverse range of pharmaceutical products, including tablets, capsules, syrups, and injections. Steril-Gene Life Sciences is a joint venture between Madras Pharmaceuticals, India, and Lloyd Laboratories, Philippines, both with over 40 years of experience in the pharmaceutical industry. The company's authorized capital is ₹2,160,000,000, with a paid-up capital of ₹2,126,389,560.

Steril-Gene Life Sciences operates a world-class manufacturing facility in Puducherry, India, covering approximately 81,000 square meters and operational since 2010. The facility is designed to meet US FDA standards and produces a wide range of pharmaceutical products, including tablets, capsules, syrups, and injections. The plant is divided into four separate manufacturing units based on the category of the drug, with a built-up area of approximately 40,000 square meters. This strategic division ensures specialized production processes and adherence to global regulatory and cGMP norms.

Steril-Gene Life Sciences Private Limited is led by a team of experienced professionals. The company's directors include Sivasamy Manohar, Sulaiman Abdulhai Mohammed, Zenaida Dizon Balajadia, Lloyd Dizon Balajadia, Dennis Dizon Balajadia, Dick Dizon Balajadia, Maximo Ponce Balajadia, Alagappan ., Krishnamurthy Balakumar, Kannappan Nagappan, Chanpreet Singh Anand, and Pabitti Manjulatha. These leaders bring a wealth of experience from various sectors within the pharmaceutical industry, contributing to the company's strategic direction and operational excellence.

Steril-Gene Life Sciences Private Limited has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Puducherry is built to US FDA standards, indicating compliance with stringent regulatory requirements. Steril-Gene Life Sciences has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. The company's adherence to global regulatory standards underscores its commitment to quality and safety in its pharmaceutical products.

Steril-Gene Life Sciences Private Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's manufacturing facility in Puducherry is built to US FDA standards, indicating compliance with stringent regulatory requirements. Steril-Gene Life Sciences has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. The company's adherence to global regulatory standards underscores its commitment to quality and safety in its pharmaceutical products.

Steril-Gene Life Sciences Private Limited has strategically diversified its geographic presence to mitigate concentration risk. The company's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. Steril-Gene Life Sciences has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. This global footprint enables the company to serve a wide range of markets, enhancing its resilience and growth prospects.

Steril-Gene Life Sciences Private Limited's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited has obtained regulatory approvals from various international authorities, including the WHO and EU GMP, facilitating market access in these regions. The company's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited operates in a competitive landscape, with several key players in the pharmaceutical manufacturing sector. The company's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions. Steril-Gene Life Sciences has a dedicated regulatory team to facilitate product registrations in various countries, preparing dossiers in CTD, ECTD, and ACTD formats as per specific country requirements.

Steril-Gene Life Sciences Private Limited's manufacturing facility in Puducherry, India, is built to US FDA standards, indicating compliance with stringent regulatory requirements. The company has obtained regulatory approvals from various international authorities, including the US FDA, WHO, MHRA, and TGA, facilitating market access in these regions.